It is very uncertain whether summary of findings table ‐ Planned hospital birth changes baby not breastfed compared with planned home birth (very low certainty).

1 finding from 1 review

Planned hospital birth compared with planned home birth for pregnant women at low risk of complications 2023 · Cochrane Headline outcomes only
OR 1.84 [0.15, 23.38]
1 study · 11 participants
Very low

Summary of findings table ‐ Planned hospital birth vs Planned home birth

Maternal satisfaction ‐ not reported · Pregnant women at low risk of complications

The review found no eligible studies for this question.

1 finding from 1 review

Planned hospital birth compared with planned home birth for pregnant women at low risk of complications 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lifestyle interventions vs placebo or usual care

Overall survival (12 months) · weight reduction in obesity to improve survival in women with endometrial cancer

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 2 participants
Low

Lifestyle interventions vs placebo or usual care

Overall survival (24 months) · weight reduction in obesity to improve survival in women with endometrial cancer

It is very uncertain whether summary of findings table ‐ Lifestyle intervention changes overall survival (24 months) compared with usual care compared to placebo (very low certainty).

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
RR 0.23 [0.01, 4.55]
1 study · 37 participants
Very low

Lifestyle interventions vs placebo or usual care

Adverse events – musculoskeletal · weight reduction in obesity to improve survival in women with endometrial cancer

It is very uncertain whether summary of findings table ‐ Lifestyle intervention changes adverse events – musculoskeletal compared with usual care compared to placebo (very low certainty).

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
RR 19.03 [1.17, 310.52]
8 studies · 315 participants
Very low

Lifestyle interventions vs placebo or usual care

Cancer‐specific survival (24 months) (Number of cancer‐related deaths) · weight reduction in obesity to improve survival in women with endometrial cancer

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 5 participants
Low

Lifestyle interventions vs placebo or usual care

Weight loss (change in kg weight) · weight reduction in obesity to improve survival in women with endometrial cancer

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 209 participants
Low

Lifestyle interventions vs placebo or usual care

Cardiovascular and metabolic event frequency (12 months) (Number of strokes, myocardial infarctions and hospitalisations for heart failure) · weight reduction in obesity to improve survival in women with endometrial cancer

Summary of findings table ‐ Lifestyle intervention showed no clear difference in cardiovascular and metabolic event frequency (6 months) compared with usual care compared to placebo (low certainty).

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
RR 3.47 [0.15, 82.21]
5 studies · 211 participants
Low

Lifestyle interventions vs placebo or usual care

Quality of life: FACT‐G (12 months) · weight reduction in obesity to improve survival in women with endometrial cancer

1 finding from 1 review

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 89 participants
Very low

Summary of findings 1: blue‐light filtering lenses vs non blue‐light filtering IOL

Visual fatigue score, measured using a Likert scale or VAS, with · adults

1 finding from 1 review

Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 120 participants
Low

Summary of findings 1: blue‐light filtering lenses vs non blue‐light filtering IOL

CFF, measured in Hz, with a · adults

1 finding from 1 review

Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 120 participants
Low

Summary of findings 1: blue‐light filtering lenses vs non blue‐light filtering IOL

BCVA, measured in log units, with · adults

1 finding from 1 review

Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 156 participants
Moderate

Summary of findings 1: blue‐light filtering lenses vs non blue‐light filtering IOL

Proportion of eyes or individuals that developed macular structural changes · adults

The review found no eligible studies for this question.

1 finding from 1 review

Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings 1: blue‐light filtering lenses vs non blue‐light filtering IOL

Colour discrimination, measured as the proportion of eyes that had a measurable loss from baseline using Farnsworth‐Munsell 100‐hue colour test score under photopic conditions at six months · adults

The review found no eligible studies for this question.

1 finding from 1 review

Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings 1: blue‐light filtering lenses vs non blue‐light filtering IOL

Subjective sleep scores, measured using a VAS or Likert scale, with · adults

1 finding from 1 review

Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 148 participants
Very low